BRAMOX, also known by its generic name brimonidine, is a medication primarily used in the treatment of open-angle glaucoma and ocular hypertension. It belongs to a class of drugs known as alpha-2 adrenergic receptor agonists. By stimulating alpha-2 receptors in the eye, BRAMOX effectively reduces the amount of fluid produced within the eye, thereby decreasing intraocular pressure. This reduction in pressure can help prevent damage to the optic nerve and loss of vision associated with glaucoma. BRAMOX is typically administered in the form of eye drops and is praised for its targeted action and effectiveness in managing conditions related to elevated intraocular pressure.